Engineering a long acting, non-biased relaxin agonist using Protein-in-Protein technology - ScienceDirect
商品説明・詳細
送料・お届け
商品情報
Engineering a long acting, non-biased relaxin agonist using Protein-in-Protein technology - ScienceDirect,Efficacy of durvalumab plus chemotherapy in advanced biliary duct cancer and biomarkers exploration | Cancer Immunology, Immunotherapy,Optimization of hybrid microperforated panel and nonuniform space-coiling channels for broadband low-frequency acoustic absorption - ScienceDirect,Frontiers | Effective Combinations of Immunotherapy and Radiotherapy for Cancer Treatment,Lords of the Mountains | Heidelberg University Publishing